| Dr Alicia Velean Lee, MD | |
|
7070 Samuel Morse Dr, Columbia, MD 21046-3424 | |
| (410) 309-4600 | |
| (410) 309-3357 |
| Full Name | Dr Alicia Velean Lee |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 7070 Samuel Morse Dr, Columbia, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194023929 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A114764 (California) | Secondary |
| 207Q00000X | Family Medicine | P8268 (Texas) | Secondary |
| 207Q00000X | Family Medicine | D95451 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
EXPERTS at the University of Huddersfield are researching the emergence of a new style of family creation that sees couples "adopt" embryos and, after the child is born, remain in contact with the donors and in many cases develop a special relationship with them.
The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a "silver bullet" to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced it has received a patent from China's State Intellectual Property Bureau for its Aoxing Ganbao product. The patent number is 551073.
Researchers from the University of Maryland School of Medicine, for the first time have put a patient in "suspended animation" successfully. Using this method, they lowered the body temperature of the human patient for the first time. This would help surgeons to prolong the time of surgery to correct traumatic injuries. The plan of their feat was published in the latest issue of the New Scientist last week.
› Verified 7 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043378656 PECOS PAC ID: 3779495858 Enrollment ID: O20080519000558 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
EXPERTS at the University of Huddersfield are researching the emergence of a new style of family creation that sees couples "adopt" embryos and, after the child is born, remain in contact with the donors and in many cases develop a special relationship with them.
The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a "silver bullet" to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced it has received a patent from China's State Intellectual Property Bureau for its Aoxing Ganbao product. The patent number is 551073.
Researchers from the University of Maryland School of Medicine, for the first time have put a patient in "suspended animation" successfully. Using this method, they lowered the body temperature of the human patient for the first time. This would help surgeons to prolong the time of surgery to correct traumatic injuries. The plan of their feat was published in the latest issue of the New Scientist last week.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alicia Velean Lee, MD 7070 Samuel Morse Dr, Columbia, MD 21046-3424 Ph: (410) 309-4600 | Dr Alicia Velean Lee, MD 7070 Samuel Morse Dr, Columbia, MD 21046-3424 Ph: (410) 309-4600 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
EXPERTS at the University of Huddersfield are researching the emergence of a new style of family creation that sees couples "adopt" embryos and, after the child is born, remain in contact with the donors and in many cases develop a special relationship with them.
The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a "silver bullet" to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced it has received a patent from China's State Intellectual Property Bureau for its Aoxing Ganbao product. The patent number is 551073.
Researchers from the University of Maryland School of Medicine, for the first time have put a patient in "suspended animation" successfully. Using this method, they lowered the body temperature of the human patient for the first time. This would help surgeons to prolong the time of surgery to correct traumatic injuries. The plan of their feat was published in the latest issue of the New Scientist last week.
› Verified 7 days ago
Daliah Walid Halboni, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 6350 Stevens Forest Rd Ste 102, Columbia, MD 21046 Phone: 443-259-3770 | |
Dr. Steve Eric Phurrough, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6179 Devon Dr, Columbia, MD 21044 Phone: 410-730-8919 | |
Dr. Muleta Tadesse Obsu, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6990 Columbia Gateway Dr, Suite 350, Columbia, MD 21046 Phone: 410-872-8590 Fax: 410-872-0141 | |
Francis C. Bruno, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11085 Little Patuxent Parkway, Suite 104, Columbia, MD 21044 Phone: 410-997-2770 Fax: 410-997-0066 | |
Antoinette M Cheney, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5450 Knoll North Dr, Suite 250, Columbia, MD 21045 Phone: 410-964-6200 Fax: 410-964-6293 | |
Ina Grundmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Nava Health And Vitality Center, 8880 Mcgaw Rd, Columbia, MD 21045 Phone: 410-910-6156 | |
Irma Bensinger, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Suite 250, Columbia, MD 21045 Phone: 410-964-6200 Fax: 410-964-6392 |